CA2633411A1 — Diaryl ureas for treating inflammatory skin, eye and/or ear diseases
Assigned to Bayer AG · Expires 2007-06-21 · 19y expired
What this patent protects
The present invention relates to pharmaceutical compositions for treating inflammatory skin, eye and/or ear diseases comprising at least a diaryl urea compound optionally combined with at least one additional therapeutic agent. Useful combinations include e.g. BAY 43-9006 as a d…
USPTO Abstract
The present invention relates to pharmaceutical compositions for treating inflammatory skin, eye and/or ear diseases comprising at least a diaryl urea compound optionally combined with at least one additional therapeutic agent. Useful combinations include e.g. BAY 43-9006 as a diaryl urea compound.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.